NBIX logo

Neurocrine Biosciences (NBIX) Net Margin

Annual Net Margin

14.49%
+1.26%+9.52%

December 1, 2024


Summary


Performance

NBIX Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNBIXprofitabilitymetrics:

Quarterly Net Margin

16.43%
-4.43%-21.24%

December 1, 2024


Summary


Performance

NBIX Quarterly Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNBIXprofitabilitymetrics:

Net Margin Formula

Net Margin =  Net Income
Revenue
✕ 100%

NBIX Net Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.5%+95.1%
3 y3 years+83.4%+95.1%
5 y5 years+209.0%+95.1%

NBIX Net Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+83.4%-42.7%+190.2%
5 y5-year-62.8%+209.0%-42.7%+173.7%
alltimeall time-70.1%+100.1%-78.2%+100.0%

Neurocrine Biosciences Net Margin History

DateAnnualQuarterly
Dec 2024
14.49%(+9.5%)
16.43%(-21.2%)
Sep 2024
-
20.86%(+89.5%)
Jun 2024
-
11.01%(+30.8%)
Mar 2024
-
8.42%(-70.6%)
Dec 2023
13.23%(+27.5%)
28.67%(+72.1%)
Sep 2023
-
16.66%(-21.0%)
Jun 2023
-
21.10%(-215.8%)
Mar 2023
-
-18.22%(-184.4%)
Dec 2022
10.38%(+31.4%)
21.60%(+22.3%)
Sep 2022
-
17.66%(-495.1%)
Jun 2022
-
-4.47%(-199.8%)
Mar 2022
-
4.48%(-291.5%)
Dec 2021
7.90%(-79.7%)
-2.34%(-130.8%)
Sep 2021
-
7.60%(-48.1%)
Jun 2021
-
14.64%(+7.9%)
Mar 2021
-
13.57%(-160.9%)
Dec 2020
38.94%(+730.3%)
-
Sep 2020
-
-22.28%(-184.7%)
Jun 2020
-
26.32%(+66.9%)
Mar 2020
-
15.77%(+13.2%)
Dec 2019
4.69%(+0.2%)
13.93%(-42.5%)
Sep 2019
-
24.22%(-13.4%)
Jun 2019
-
27.96%(-137.9%)
Mar 2019
-
-73.77%(-636.9%)
Dec 2018
4.68%(-105.3%)
13.74%(-58.9%)
Sep 2018
-
33.45%(-648.4%)
Jun 2018
-
-6.10%(-89.6%)
Mar 2018
-
-58.83%(-907.0%)
Dec 2017
-88.19%(-90.6%)
7.29%(-139.8%)
Sep 2017
-
-18.31%(-98.1%)
Jun 2017
-
-946.88%(+637.3%)
Dec 2016
-940.60%(+109.1%)
-
Mar 2016
-
-128.43%(+2029.9%)
Dec 2015
-449.84%(-71.5%)
-
Mar 2015
-
-6.03%(-99.6%)
Dec 2013
-1578.97%(<-9900.0%)
-1457.81%(-4.5%)
Sep 2013
-
-1526.89%(-9.0%)
Jun 2013
-
-1676.99%(+1.4%)
Mar 2013
-
-1654.11%(-3925.4%)
Dec 2012
9.46%(-80.5%)
43.24%(-231.4%)
Sep 2012
-
-32.90%(+594.1%)
Jun 2012
-
-4.74%(-39.7%)
Mar 2012
-
-7.86%(-165.6%)
Dec 2011
48.53%(-304.1%)
11.98%(-84.1%)
Sep 2011
-
75.38%(+363.9%)
Jun 2011
-
16.25%(-29.4%)
Mar 2011
-
23.03%(+26.5%)
Dec 2010
-23.78%(-98.6%)
18.21%(-21.1%)
Sep 2010
-
23.07%(-102.0%)
Mar 2010
-
-1146.88%(+7.2%)
Dec 2009
-1728.34%
-1069.73%(-4.1%)
Sep 2009
-
-1115.55%(-46.5%)
DateAnnualQuarterly
Jun 2009
-
-2084.58%(-20.8%)
Mar 2009
-
-2632.53%(-33.5%)
Dec 2008
-2229.26%(-86.8%)
-3958.02%(+70.1%)
Sep 2008
-
-2327.33%(-18.5%)
Jun 2008
-
-2857.08%(+137.4%)
Mar 2008
-
-1203.71%(-95.0%)
Dec 2007
-16.94 K%(+6098.1%)
-24.06 K%(+376.9%)
Sep 2007
-
-5044.44%(-90.8%)
Jun 2007
-
-54.92 K%(+122.1%)
Mar 2007
-
-24.73 K%(>+9900.0%)
Dec 2006
-273.25%(+1425.7%)
-155.85%(-95.7%)
Sep 2006
-
-3644.60%(+1127.4%)
Jun 2006
-
-296.94%(+123.3%)
Mar 2006
-
-132.99%(-21.5%)
Dec 2005
-17.91%(-66.7%)
-169.43%(-519.5%)
Sep 2005
-
40.39%(-339.0%)
Jun 2005
-
-16.90%(-89.4%)
Mar 2005
-
-158.72%(+42.3%)
Dec 2004
-53.74%(+147.1%)
-111.52%(+2247.8%)
Sep 2004
-
-4.75%(-93.6%)
Jun 2004
-
-73.97%(+1.2%)
Mar 2004
-
-73.08%(-720.9%)
Dec 2003
-21.75%(-95.8%)
11.77%(-135.0%)
Sep 2003
-
-33.61%(+47.8%)
Jun 2003
-
-22.74%(-35.9%)
Mar 2003
-
-35.50%(-96.5%)
Dec 2002
-523.89%(+485.4%)
-1000.18%(+146.3%)
Sep 2002
-
-406.06%(-13.1%)
Jun 2002
-
-467.26%(+46.9%)
Mar 2002
-
-318.01%(+179.3%)
Dec 2001
-89.50%(-54.7%)
-113.85%(-1080.6%)
Sep 2001
-
11.61%(-102.9%)
Jun 2001
-
-400.96%(+22.0%)
Mar 2001
-
-328.64%(+23.5%)
Dec 2000
-197.48%(+97.5%)
-266.12%(+74.1%)
Sep 2000
-
-152.83%(-13.4%)
Jun 2000
-
-176.48%(-18.9%)
Mar 2000
-
-217.67%(+147.1%)
Dec 1999
-100.00%(-20.0%)
-88.10%(+4.1%)
Sep 1999
-
-84.62%(-29.9%)
Jun 1999
-
-120.73%(+6.0%)
Mar 1999
-
-113.89%(-24.6%)
Dec 1998
-125.00%(-739.7%)
-151.11%(+92.7%)
Sep 1998
-
-78.43%(-77.5%)
Jun 1998
-
-347.83%(+1088.3%)
Mar 1998
-
-29.27%(<-9900.0%)
Dec 1997
19.54%(-36.4%)
0.00%(-100.0%)
Sep 1997
-
12.90%(+520.2%)
Jun 1997
-
2.08%(-95.5%)
Mar 1997
-
46.07%(-4.8%)
Dec 1996
30.73%
48.39%(-366.2%)
Sep 1996
-
-18.18%(-155.5%)
Jun 1996
-
32.73%

FAQ

  • What is Neurocrine Biosciences annual net profit margin?
  • What is the all time high annual net margin for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual net margin year-on-year change?
  • What is Neurocrine Biosciences quarterly net profit margin?
  • What is the all time high quarterly net margin for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly net margin year-on-year change?

What is Neurocrine Biosciences annual net profit margin?

The current annual net margin of NBIX is 14.49%

What is the all time high annual net margin for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual net profit margin is 48.53%

What is Neurocrine Biosciences annual net margin year-on-year change?

Over the past year, NBIX annual net profit margin has changed by +1.26% (+9.52%)

What is Neurocrine Biosciences quarterly net profit margin?

The current quarterly net margin of NBIX is 16.43%

What is the all time high quarterly net margin for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly net profit margin is 75.38%

What is Neurocrine Biosciences quarterly net margin year-on-year change?

Over the past year, NBIX quarterly net profit margin has changed by +8.01% (+95.13%)